Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,728 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Acquired von Willebrand syndrome: an update.
Franchini M, Lippi G. Franchini M, et al. Am J Hematol. 2007 May;82(5):368-75. doi: 10.1002/ajh.20830. Am J Hematol. 2007. PMID: 17133419 Review.
Milestones and perspectives in coagulation and hemostasis.
Lippi G, Favaloro EJ, Franchini M, Guidi GC. Lippi G, et al. Semin Thromb Hemost. 2009 Feb;35(1):9-22. doi: 10.1055/s-0029-1214144. Epub 2009 Mar 23. Semin Thromb Hemost. 2009. PMID: 19308889 Review.
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G, Franchini M, Salvagno GL, Montagnana M, Poli G, Guidi GC. Lippi G, et al. J Thromb Thrombolysis. 2008 Oct;26(2):150-3. doi: 10.1007/s11239-007-0090-0. Epub 2007 Sep 3. J Thromb Thrombolysis. 2008. PMID: 17786534
Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies?
Lippi G, Franchini M, Poli G, Salvagno GL, Montagnana M, Guidi GC. Lippi G, et al. Blood Coagul Fibrinolysis. 2007 Jun;18(4):361-4. doi: 10.1097/MBC.0b013e32810fd872. Blood Coagul Fibrinolysis. 2007. PMID: 17473578 Clinical Trial.
Air pollution and coagulation testing: a new source of biological variability?
Lippi G, Favaloro EJ, Franchini M, Guidi GC. Lippi G, et al. Thromb Res. 2008;123(1):50-4. doi: 10.1016/j.thromres.2008.04.010. Epub 2008 Jun 10. Thromb Res. 2008. PMID: 18547620 Review.
von Willebrand factor and cancer: a renewed interest.
Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G. Franchini M, et al. Thromb Res. 2013 Apr;131(4):290-2. doi: 10.1016/j.thromres.2013.01.015. Epub 2013 Feb 8. Thromb Res. 2013. PMID: 23394808 Review.
Inside out the thrombus: Defining the role of von Willebrand factor.
Franchini M, Lippi G. Franchini M, et al. Thromb Res. 2016 Aug;144:234-5. doi: 10.1016/j.thromres.2016.06.027. Epub 2016 Jun 28. Thromb Res. 2016. PMID: 27388222 No abstract available.
Biological therapies for von Willebrand disease.
Favaloro EJ, Franchini M, Lippi G. Favaloro EJ, et al. Expert Opin Biol Ther. 2012 May;12(5):551-64. doi: 10.1517/14712598.2012.667398. Epub 2012 Mar 20. Expert Opin Biol Ther. 2012. PMID: 22428722 Review.
Most developed countries currently use standard therapy to manage bleeding, employing desmopressin wherever possible, factor concentrate in other situations and additional (e.g., antifibrinolytic) therapy when required. ...
Most developed countries currently use standard therapy to manage bleeding, employing desmopressin wherever possible, factor concentrate in …
1,728 results
Jump to page
Feedback